Key result
A 252-lead body surface mapping system identified abnormal repolarization patterns in all ARVC patients and 25% of healthy gene carriers, suggesting utility for early disease detection.
Why the study?
Diagnosing ARVC at an early stage can be challenging even after ECG recording and imaging, prompting evaluation of whether a 252-lead BSM system could identify repolarization abnormalities.
Does a 252-lead BSM system identify early repolarization abnormalities in ARVC patients and healthy gene carriers compared to standard ECG?
Cross-Sectional (n=40)
Does a 252-lead BSM system identify early repolarization abnormalities in ARVC patients and healthy gene carriers compared to standard ECG?
A 252-lead body surface mapping system can detect early repolarization abnormalities in ARVC gene carriers who otherwise have normal standard 12-lead ECGs.
BSM may aid early ARVC detection in gene carriers with normal ECGs; hypothesis-generating and requires prospective validation before any practice change.
BACKGROUND: Diagnosing arrhythmogenic right ventricular cardiomyopathy (ARVC) at an early stage can be challenging even after ECG recording and a combination of several imaging techniques. The purpose of this study was to explore if a body surface mapping (BSM) system with 252-leads could identify repolarization abnormalities and thereby diagnose early stages of ARVC. METHODS: ARVC patients, gene carriers without signs of ARVC and controls underwent a 12-lead resting ECG, signal-averaged ECG, echocardiography, 24-hours Holter monitoring, and BSM with electrocardiographic imaging (ECGI). All 252-leads, divided into four quadrants of the vest, were analyzed regarding concordances between T wave polarity and QRS main vector. RESULTS: Of 40 patients included there were 12 ARVC patients, 20 gene carriers, and 8 controls. The ARVC patients had two different repolarization patterns, one with more pronounced negative T waves at the lower left panel and another with mixed changes that clearly differed from the controls, all of whom had a normal 12 lead ECGs and consistent repolarization patterns on their BSM recordings. The patterns observed in ARVC patients were also present in 5/20 (25%) gene carriers, three of whom had normal resting ECG. A novel repolarization index successfully detected all ARVC patients and 88% of gene carriers with pathologic repolarization pattern. CONCLUSIONS: The finding that abnormal repolarization patterns could be unmasked by BSM in 25% of healthy gene carriers, suggests that it may potentially be a useful tool for identifying early manifestations of ARVC. Further and larger studies are warranted to assess its diagnostic accuracy.
No takes yet. Share an insight, caveat, or question.
Kommata et al. (2022) conducted a cross-sectional in Arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=40). 252-lead body surface mapping (BSM) system vs. Controls was evaluated on Detection of repolarization abnormalities. A 252-lead body surface mapping system identified abnormal repolarization patterns in all ARVC patients and 25% of healthy gene carriers, suggesting utility for early disease detection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: